MENU
GOSS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Gossamer Bio (GOSS) Earnings Date & Reports

A.I. Advisor
published Earnings

GOSS is expected to report earnings to rise 20.14% to -16 cents per share on March 21

Gossamer Bio GOSS Stock Earnings Reports
Q4'24
Est.
$-0.17
Q3'24
Beat
by $0.01
Q2'24
Missed
by $0.29
Q1'24
Est.
$-0.19
Q4'23
Est.
$-0.21
The last earnings report on November 08 showed earnings per share of -14 cents, beating the estimate of -15 cents. With 150.55K shares outstanding, the current market capitalization sits at 197.71M.
View a ticker or compare two or three
GOSS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a company, which engages in discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
3013 Science Park Road
Phone
+1 858 684-1300
Employees
135
Web
https://www.gossamerbio.com